UBS Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.59M | Sell |
315,167
-162,229
| -34% | -$818K | ﹤0.01% | 4004 |
|
2025
Q1 | $3.09M | Buy |
477,396
+237,283
| +99% | +$1.54M | ﹤0.01% | 3370 |
|
2024
Q4 | $1.76M | Sell |
240,113
-143,075
| -37% | -$1.05M | ﹤0.01% | 3815 |
|
2024
Q3 | $2.87M | Buy |
383,188
+89,713
| +31% | +$672K | ﹤0.01% | 2748 |
|
2024
Q2 | $2.61M | Sell |
293,475
-172,733
| -37% | -$1.54M | ﹤0.01% | 2613 |
|
2024
Q1 | $4.72M | Sell |
466,208
-59,972
| -11% | -$608K | ﹤0.01% | 2247 |
|
2023
Q4 | $5.29M | Buy |
526,180
+240,648
| +84% | +$2.42M | ﹤0.01% | 1970 |
|
2023
Q3 | $2.68M | Buy |
285,532
+74,704
| +35% | +$700K | ﹤0.01% | 2326 |
|
2023
Q2 | $5.17M | Buy |
210,828
+88,702
| +73% | +$2.18M | ﹤0.01% | 1877 |
|
2023
Q1 | $2.84M | Sell |
122,126
-167,601
| -58% | -$3.9M | ﹤0.01% | 2277 |
|
2022
Q4 | $7.33M | Buy |
289,727
+185,199
| +177% | +$4.69M | ﹤0.01% | 1548 |
|
2022
Q3 | $2.02M | Sell |
104,528
-22,347
| -18% | -$431K | ﹤0.01% | 2352 |
|
2022
Q2 | $3.23M | Sell |
126,875
-194,178
| -60% | -$4.94M | ﹤0.01% | 2064 |
|
2022
Q1 | $8.26M | Buy |
321,053
+225,346
| +235% | +$5.8M | ﹤0.01% | 1574 |
|
2021
Q4 | $4.01M | Buy |
95,707
+75,375
| +371% | +$3.16M | ﹤0.01% | 2298 |
|
2021
Q3 | $884K | Sell |
20,332
-1,459
| -7% | -$63.4K | ﹤0.01% | 3344 |
|
2021
Q2 | $1.03M | Sell |
21,791
-13,185
| -38% | -$623K | ﹤0.01% | 3223 |
|
2021
Q1 | $1.79M | Sell |
34,976
-10,515
| -23% | -$539K | ﹤0.01% | 2856 |
|
2020
Q4 | $1.22M | Sell |
45,491
-19,930
| -30% | -$534K | ﹤0.01% | 3015 |
|
2020
Q3 | $2.25M | Buy |
65,421
+27,993
| +75% | +$961K | ﹤0.01% | 2322 |
|
2020
Q2 | $1.53M | Buy |
37,428
+33,241
| +794% | +$1.36M | ﹤0.01% | 2494 |
|
2020
Q1 | $143K | Sell |
4,187
-7,770
| -65% | -$265K | ﹤0.01% | 4140 |
|
2019
Q4 | $150K | Buy |
+11,957
| New | +$150K | ﹤0.01% | 4767 |
|